阿摩線上測驗
6.下列藥物何者不是治療慢性骨髓性白血病？
(A)Imatinib
(B)Dasatinib
(C)Gefitinib
(D)Nilotinib
統計： A(701), B(897), C(5545), D(788), E(0) #1738087
詳解 (共 10 筆)
前人口訣提供
Imatinib 愛罵
Nilotinib 你
Dasatinib 大傻
72 下列抗癌藥中，屬於訊息傳遞（signal transduction）抑制劑者為：
(A) Arsenic trioxide
(B) Etoposide
(C) Imatinib
(D) Interferon alpha-2a
68.Imatinib（Gleevec）抗癌作用機轉是抑制癌細胞何種酵素？
(A)Reverse transcriptase
(B)Neuraminidase
(C)Tyrosine kinase
(D)Ribonucleotide reductase
44 下列那一個藥品是tyrosine kinase 的抑制劑，臨床上用來治療 chronic myelogenous leukemia（CML）？
(A) Carbidopa
(B) Allopurinol
(C) Imatinib
(D) Theophylline
(A)Imatinib
(B)Bevacizumab
(C)Celecoxib
(D)Rituximab
<標靶單抗整理>
慢性骨髓性白血病(CML):Imatinib,Dasatinib,Nilotinib
急性淋巴性白血病(ALL):Imatinib,Dasatinib,Nilotinib
慢性淋巴性白血病(CLL):Alemtuzumab
非何傑金氏淋巴瘤(NHL):Rituximab,Ibritumomab
腎臟癌(RCC):Bevacizumab,Sorafenib,Sunitinib,Pazopanib
肝癌:Sorafenib
胃腸道間質瘤(GIST):Imatinib,Sunitinib,Pazopanib
大腸癌:Bevacizumab,Cetuximab,Panitumumab
非小細胞肺癌(NSCLC):Gefitinib,Erlotinib,Bevacizumab
乳癌:Trastuzumab,Lapatinib
胰臟癌:Erlotinib
補充合併製劑(整理自學校老師講義)
|
適應症 |
組合 |
||
|
頭頸癌 |
CF |
Cisplatin + Fluorouracil |
|
|
PCV |
Procarbazine + Carmustine + Vincristine |
||
|
乳癌 |
CMF |
Cyclophosphamide + Methotrexate+ Fluorouracil |
|
|
CAF |
Cyclophosphamide + Doxorubicin (Adriamycin) + Fluorouracil |
||
|
AC |
Doxorubicin (Adriamycin) + Cyclophosphamide |
||
|
Herceptin-tax |
Trastuzumab (Herceptin) + Paclitaxel |
||
|
大腸直腸癌 |
FU/leucovorin |
Fluorouracil + Leucovorin(↑5FU作用) |
|
|
IFL、FOLFIRI |
Irinotecan + Fluorouracil + Leucovorin |
||
|
FOLFOX4 |
Oxaliplatin + Fluorouracil + Leucovorin |
||
|
胃癌 |
ECP |
Epirubicin + Cisplatin + Fluorouracil |
|
|
FAM |
Fluorouracil + Doxorubicin (Adriamycin) + Mitomycin |
||
|
EAP |
Etoposide + Doxorubicin (Adriamycin) + Cisplatin |
||
|
膀胱癌 |
M-VAC |
Methotrexate + Vinblastine + Doxorubicin (Adriamycin) |
|
|
PC |
Paclitaxel + Carboplatin |
||
|
卵巢癌 |
CP |
Cyclophosphamide + Cisplatin |
|
|
CT |
Paclitaxel + Cisplatin |
||
|
Carbo-tax |
Paclitaxel + Carboplatin |
||
|
睪丸癌 |
BEP |
Bleomycin + Etoposide + Cisplatin |
|
|
EP |
Etoposide + Cisplatin |
||
|
肺癌 |
SCLC |
EP |
Etoposide + Cisplatin |
|
NSCLC |
EP |
Etoposide + Cisplatin |
|
|
EC |
Etoposide + Carboplatin |
||
|
Carbo-tax |
Paclitaxel + Carboplatin |
||
|
Gemcitabine-Cis |
Gemcitabine + Cisplatin |
||
|
Docetaxel- Cisplatin |
Docetaxel + Cisplatin |
||
|
淋巴癌 |
NHL |
CHOP★ |
Cyclophosphamide + Doxorubicin + Vincristine (Oncovin) + Prednisone |
|
CHOP-Rituximab |
CHOP + Rituximab |
||
|
MACOP-B |
CHOP +Leucovorin + Methotrexate + Bleomycin |
||
|
ESHAP |
Etoposide + Methylprednisolone + Cisplatin + Cytarabine |
||
|
HL |
MOPP★ |
Mechlorethamine(Mustargen®) + Vincristin (Oncovin) + Prednisone + Procarbazine |
|
|
ABVD★ |
Doxorubicin (Adriamycin) + Bleomycin + Vinblastine + Dacarbazine |
||
|
多發性 骨髓瘤 |
VAD |
Vincristine (Oncovin) + Doxorubicin (Adriamycin) + Dexamethasone |
|
|
MP |
Melphalan + Prednisone |
||
Gefitinib 抑制 TKI 治療 非小細胞肺癌 Imatinib Dasatinib Nilotinib 抑制BCR-ABL Tyrosine kinase 治療慢性骨隨性白血病
<比較>
治療AML: cytarabine
